Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22946,94,1.02 [0.86-1.22],0.7983065321623832
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23575,176,0.93 [0.81-1.05],0.249019029023362
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23343,1146,1.02 [0.97-1.07],0.4634358602601038
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,23601,405,1.03 [0.95-1.13],0.4557541259509238
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22859,2993,1.02 [0.98-1.05],0.3362541450485524
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23076,2431,1.01 [0.97-1.04],0.7395535112421454
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23361,1167,1.03 [0.97-1.08],0.3284362798859274
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23507,78,0.95 [0.79-1.16],0.6339053348640564
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22043,693,0.99 [0.93-1.06],0.832010240137807
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21292,789,0.99 [0.93-1.05],0.7864268914323814
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21340,217,1.01 [0.89-1.13],0.9188699365931208
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16525,1403,1.01 [0.96-1.06],0.6830250630676455
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21149,315,1.02 [0.93-1.13],0.6459710061103755
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23546,1352,1.01 [0.96-1.06],0.7384091989833403
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Mycoses,23654,458,1.05 [0.96-1.13],0.2779317231886209
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23007,810,1.00 [0.94-1.06],0.9122728273019508
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23609,757,1.00 [0.94-1.06],0.9547188605959795
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22370,176,0.93 [0.82-1.06],0.2574991751809687
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23713,35,1.07 [0.80-1.44],0.6556570112302412
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23524,672,0.99 [0.93-1.06],0.7878624421948093
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23503,74,0.91 [0.75-1.11],0.3738723348138816
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23630,165,1.10 [0.96-1.26],0.1725189097427854
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23615,150,1.08 [0.94-1.25],0.2779911774101302
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22493,296,1.06 [0.96-1.17],0.2859499717956333
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22422,225,1.05 [0.93-1.18],0.4307498146575014
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22292,98,1.12 [0.94-1.34],0.196478055467352
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23690,35,1.05 [0.79-1.40],0.744479210217913
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23645,140,0.98 [0.84-1.13],0.7322919495223774
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Viral warts,23547,42,1.15 [0.88-1.51],0.3085858324008101
APPL2,DCC-interacting protein 13-beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23576,71,0.94 [0.76-1.15],0.5193994742966244
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm,23473,204,1.13 [1.00-1.28],0.0488822568675888
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23623,60,1.07 [0.86-1.34],0.53607703930841
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23615,59,1.39 [1.10-1.75],0.005588957272203
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23463,1049,1.01 [0.95-1.06],0.8230419623610964
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of meninges,23689,72,1.01 [0.82-1.24],0.9202397454344412
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23655,58,1.06 [0.84-1.34],0.6061362404749666
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23682,116,1.08 [0.92-1.27],0.3491230223697287
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm of ovary,23644,149,0.98 [0.85-1.13],0.7895229627771928
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23693,236,0.92 [0.83-1.03],0.1691734634267813
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Caecum,23699,216,0.95 [0.85-1.07],0.3889475263270691
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23631,60,0.89 [0.72-1.11],0.2926433335291324
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,23698,131,0.86 [0.74-1.00],0.0504725969242122
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Rectum,23659,240,1.00 [0.89-1.11],0.9353667234623256
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23618,442,1.01 [0.93-1.10],0.7722123981095543
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23698,250,0.95 [0.86-1.06],0.3921554925184752
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Carcinoma in situ of breast,19191,120,0.85 [0.73-0.99],0.034250469495055
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19262,139,0.95 [0.82-1.10],0.5215323809530179
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19255,29,0.76 [0.56-1.04],0.0869169913763434
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19282,56,0.96 [0.76-1.20],0.6974316804617211
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23652,123,0.90 [0.77-1.05],0.1884198487788453
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Haemangioma, any site",23653,121,0.90 [0.77-1.05],0.1937812501847386
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Leiomyoma of uterus,22843,501,0.97 [0.90-1.05],0.423567124399354
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lung cancer and mesothelioma,17005,279,0.93 [0.84-1.03],0.1827351628158089
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Lymphoid leukaemia,19258,32,0.74 [0.55-0.99],0.0432483939175434
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19379,153,1.01 [0.88-1.16],0.9274124508426886
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19322,96,0.97 [0.82-1.16],0.7584191632928542
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19390,164,0.90 [0.79-1.03],0.1283945429696623
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19288,62,1.08 [0.86-1.34],0.5154268559931796
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19289,63,1.10 [0.88-1.37],0.4076417023462322
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19274,48,0.91 [0.71-1.17],0.4718692760081889
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19352,126,0.99 [0.85-1.15],0.8859793449773623
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19318,92,1.00 [0.84-1.20],0.9844022247910202
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19297,71,0.97 [0.79-1.18],0.7365285491280469
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19260,34,0.99 [0.74-1.33],0.9640986308890648
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19296,70,0.86 [0.70-1.05],0.1409690667790451
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi,23482,205,1.10 [0.97-1.24],0.1303515321393131
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanocytic naevi of trunk,23674,69,1.12 [0.91-1.38],0.286525286016512
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Melanoma in situ,19255,75,1.14 [0.93-1.40],0.214685616264943
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19297,71,0.99 [0.81-1.22],0.9479268695239592
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19358,132,1.03 [0.89-1.20],0.6658468149702271
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19432,206,0.83 [0.74-0.94],0.0021025590951139
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19307,81,1.10 [0.91-1.34],0.3164290588861227
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,Other benign neoplasms of skin,23518,149,0.98 [0.85-1.12],0.7289207925552232
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20026,800,0.99 [0.93-1.05],0.6818216590884645
APPL2,DCC-interacting protein 13-beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20061,835,0.99 [0.93-1.05],0.7105292580158968
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23435,331,0.97 [0.88-1.07],0.5330870639734971
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21999,81,0.98 [0.81-1.19],0.846347366836053
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23172,68,1.03 [0.84-1.27],0.7852317612321407
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22840,2550,1.04 [1.00-1.08],0.027523990412864
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22315,28,1.10 [0.79-1.53],0.5673620641722452
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23368,46,1.21 [0.93-1.57],0.1508513527277353
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23213,1295,1.03 [0.98-1.08],0.2416519085632709
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23213,1295,1.03 [0.98-1.08],0.2416519085632709
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21984,66,1.00 [0.81-1.23],0.977803753983444
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23350,1063,1.10 [1.04-1.16],0.0004186467842255
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23423,101,0.91 [0.76-1.07],0.2525677938153484
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23151,47,0.87 [0.68-1.12],0.2827959125782957
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23156,52,1.05 [0.83-1.34],0.669617314605163
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23531,209,0.94 [0.84-1.06],0.3468532088472227
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23617,54,1.26 [0.99-1.60],0.0608226372555026
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23500,178,0.81 [0.71-0.91],0.0006976036593548
APPL2,DCC-interacting protein 13-beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22400,113,1.14 [0.97-1.35],0.1087900183172651
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19157,206,0.98 [0.87-1.11],0.7908191177131089
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22474,60,0.92 [0.73-1.16],0.4928507242905211
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22470,56,1.26 [0.98-1.61],0.0682866448099833
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18995,44,1.12 [0.86-1.47],0.3856655378958313
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21749,52,0.93 [0.74-1.18],0.5732831124362524
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21454,202,0.94 [0.83-1.06],0.2835894671082428
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23332,418,0.89 [0.82-0.97],0.0077823070315337
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23172,258,0.94 [0.85-1.05],0.2877327241613624
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22973,59,1.05 [0.84-1.31],0.6923373514654784
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23382,1685,1.03 [0.98-1.07],0.2285285703840163
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21013,1648,1.03 [0.99-1.08],0.1663013421772413
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18994,43,1.09 [0.84-1.43],0.50422903472477
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21080,100,1.02 [0.86-1.21],0.819792773199201
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19198,247,1.03 [0.92-1.15],0.5925349979829435
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18993,42,1.31 [0.99-1.72],0.0561949881680282
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21633,2682,1.05 [1.02-1.09],0.0028296348020573
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19131,180,0.98 [0.86-1.11],0.7164852411753607
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19424,473,1.03 [0.95-1.12],0.457661722208435
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23630,309,1.14 [1.03-1.26],0.0097996932442506
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23464,143,1.18 [1.02-1.36],0.0289377045549436
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19037,86,0.95 [0.79-1.14],0.5793984972692393
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18999,48,1.06 [0.82-1.36],0.660587595777232
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22953,1973,1.04 [1.00-1.08],0.0382869179494621
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19124,173,0.90 [0.79-1.03],0.1197278162324344
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19120,169,1.09 [0.95-1.25],0.2069766304062582
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19399,448,1.03 [0.95-1.12],0.4636899270447676
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19021,70,0.99 [0.80-1.21],0.8870956206383742
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23460,139,1.16 [1.00-1.35],0.0450378432806971
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19476,525,0.94 [0.87-1.01],0.0980518157287212
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19426,475,1.01 [0.94-1.10],0.7469789748709066
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21315,63,1.00 [0.81-1.24],0.9858691690336
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22960,4009,1.04 [1.01-1.07],0.0097711713244019
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21043,63,0.91 [0.74-1.13],0.385318652366345
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21057,77,1.00 [0.82-1.22],0.9775275149242344
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23544,1770,0.99 [0.95-1.03],0.7522481199246276
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23548,1769,0.99 [0.95-1.03],0.763830395259268
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21053,73,1.02 [0.84-1.25],0.8135129076325759
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23357,1372,1.04 [0.99-1.09],0.127317746510938
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20227,1276,0.99 [0.95-1.04],0.8277914842806995
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23702,155,0.98 [0.85-1.13],0.7798126440503521
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22952,38,1.10 [0.83-1.46],0.5219812399905954
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22099,114,0.92 [0.79-1.08],0.3283655757041274
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22153,168,1.11 [0.97-1.28],0.1163191125441869
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19169,218,1.08 [0.96-1.21],0.2178634633945676
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22135,119,1.03 [0.88-1.21],0.6886899077693327
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1479,37,0.88 [0.66-1.17],0.3766523811693959
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1570,146,1.01 [0.87-1.16],0.917426808580328
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22039,23,1.21 [0.84-1.75],0.3119436216085544
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1464,23,0.90 [0.63-1.28],0.5562819026437302
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23305,1289,1.04 [0.99-1.09],0.1146650933605285
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23203,289,0.93 [0.84-1.03],0.1791840198154756
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21664,412,1.01 [0.93-1.10],0.8566853797541205
APPL2,DCC-interacting protein 13-beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19561,610,1.02 [0.95-1.09],0.5931743890351786
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23625,206,0.85 [0.76-0.96],0.007539124926687
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22822,45,0.90 [0.70-1.15],0.3943482948532075
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Angina pectoris,22398,739,1.04 [0.98-1.11],0.2264298421694816
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22857,80,0.90 [0.75-1.09],0.2973348545881996
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22807,30,1.11 [0.81-1.53],0.5075105284558541
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22913,136,0.92 [0.80-1.07],0.2742879162053507
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15420,1269,0.98 [0.94-1.03],0.5403811462911265
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,AV-block,20784,213,1.06 [0.94-1.20],0.3079533741288228
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23673,260,0.90 [0.81-1.01],0.0619282853568396
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,14255,104,1.02 [0.86-1.21],0.830330457958229
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20688,117,0.85 [0.73-0.99],0.0389532145152875
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20642,71,1.09 [0.89-1.34],0.4124873397377543
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23709,28,0.93 [0.68-1.28],0.6669229051443382
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Conduction disorders,21203,632,1.03 [0.97-1.11],0.3441624054834765
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22919,1271,1.03 [0.98-1.08],0.2699440281314839
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21351,6303,1.02 [0.99-1.04],0.1592184149864404
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22423,219,0.89 [0.80-1.00],0.0523179668390844
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Endocarditis,20618,47,0.97 [0.76-1.25],0.8246322253799834
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23628,722,1.03 [0.97-1.10],0.3006251789623145
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertension,21885,5290,1.02 [0.99-1.04],0.1387266294995082
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21893,5298,1.02 [0.99-1.04],0.1417251723905639
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23611,37,0.74 [0.57-0.97],0.031777584443691
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16744,149,0.96 [0.83-1.10],0.5406850785268049
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16658,63,0.97 [0.79-1.21],0.8157571794970766
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Hypotension,23597,918,0.95 [0.90-1.01],0.0829375619263897
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23063,84,1.02 [0.84-1.23],0.8472565146638393
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23097,1438,1.04 [0.99-1.09],0.1216459719143576
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23441,390,1.00 [0.91-1.09],0.9584595040686592
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20836,265,1.01 [0.91-1.12],0.8649691893259285
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23522,523,1.03 [0.96-1.11],0.4403690048854671
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22078,419,1.05 [0.96-1.14],0.2708703778677624
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23688,76,1.16 [0.95-1.42],0.1486685485927388
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23705,206,1.04 [0.92-1.17],0.5477207962407629
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,22239,35,0.79 [0.59-1.05],0.0995924879899864
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other aneurysm,22827,50,0.88 [0.69-1.12],0.3008626722173479
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,20884,313,1.02 [0.93-1.13],0.6199601460958057
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22838,61,1.17 [0.93-1.46],0.1739421340111137
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22948,171,0.94 [0.82-1.07],0.3148958856988094
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20719,148,0.93 [0.81-1.07],0.2859949081651262
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,22279,75,0.98 [0.81-1.20],0.8659276420974444
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22246,42,1.07 [0.82-1.40],0.6049553695620262
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22639,31,0.74 [0.55-1.00],0.0465099754018238
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22339,135,1.02 [0.88-1.19],0.7707741515276324
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21241,670,0.99 [0.93-1.06],0.7518567103750284
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22716,37,0.95 [0.71-1.25],0.6948554336025774
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23223,446,0.94 [0.87-1.02],0.1691010485938915
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23215,280,0.90 [0.82-1.00],0.0516773919065484
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23072,464,0.94 [0.86-1.01],0.1041414032933171
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14400,249,1.00 [0.90-1.12],0.9698085237791964
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23010,245,0.93 [0.83-1.03],0.1799803334619443
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22488,284,0.95 [0.86-1.05],0.3362185537438306
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23311,376,1.01 [0.92-1.10],0.8983591318796449
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23644,490,0.95 [0.88-1.03],0.2104324111988132
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20757,186,1.03 [0.90-1.17],0.6906719027998117
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23208,273,0.91 [0.82-1.01],0.0718041824039825
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22740,132,0.89 [0.77-1.04],0.1416744717482529
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23432,453,1.00 [0.92-1.09],0.9668410814611051
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23409,494,0.99 [0.92-1.07],0.8594996038233025
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23032,62,0.98 [0.79-1.22],0.8519053381633886
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22812,35,1.17 [0.87-1.57],0.3143686048566019
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23235,184,1.10 [0.97-1.25],0.1482946487110978
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23174,175,1.02 [0.89-1.16],0.8137447642474944
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Varicose veins,22582,378,1.03 [0.94-1.12],0.5477165591842554
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22786,82,0.85 [0.71-1.02],0.0856539119412984
APPL2,DCC-interacting protein 13-beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23528,597,0.99 [0.92-1.06],0.7322827563945522
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23677,196,1.09 [0.96-1.23],0.1926503711726572
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21072,1600,1.03 [0.99-1.08],0.1519083752940589
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Any mental disorder,23198,3726,1.02 [0.99-1.05],0.1793577942618965
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23652,232,1.04 [0.93-1.17],0.4937880767265606
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21172,1700,1.03 [0.99-1.07],0.1860083093483526
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19548,76,1.02 [0.83-1.24],0.8720068467536709
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Smoking dependency,23359,1035,1.03 [0.97-1.09],0.3129847023839808
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20675,1203,1.02 [0.97-1.08],0.3463069472375293
APPL2,DCC-interacting protein 13-beta,Chapter V Mental and behavioural disorders,Vascular dementia,23293,94,0.95 [0.80-1.13],0.5707740102414034
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Alzheimer disease,23711,321,0.94 [0.86-1.04],0.2366836864902809
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16233,51,0.92 [0.72-1.17],0.4912274934685713
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Bell's palsy,21852,70,0.93 [0.76-1.14],0.4628719242135475
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22337,555,1.04 [0.96-1.12],0.3203651171855977
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral cysts,23362,184,1.00 [0.88-1.14],0.969787962330546
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23648,238,0.91 [0.81-1.01],0.0838761538599301
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23290,38,0.93 [0.71-1.23],0.6265814448662619
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23700,43,1.08 [0.83-1.41],0.5503605876907691
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23222,44,0.96 [0.74-1.24],0.7394290406185893
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Epilepsy,22447,241,0.92 [0.83-1.03],0.1619314663280197
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23349,1143,1.01 [0.96-1.06],0.8172671047679871
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23667,298,1.03 [0.93-1.14],0.5757381427927244
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23182,2487,0.94 [0.91-0.98],0.0009553098576818
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,23400,41,1.27 [0.97-1.68],0.0835376081066712
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hemiplegia,23598,188,0.93 [0.82-1.05],0.2390026381034847
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Hydrocephalus,23232,54,1.04 [0.82-1.32],0.7338586970703735
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23695,63,1.13 [0.91-1.41],0.2606045507341099
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21892,110,0.92 [0.78-1.08],0.2907080099720547
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21835,53,1.09 [0.86-1.39],0.4559335525290169
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Memory loss,23180,95,1.08 [0.91-1.29],0.3865554744144081
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Migraine,22644,438,1.02 [0.94-1.11],0.6481572947150515
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23611,396,1.01 [0.93-1.10],0.803823174190514
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Motor neuron disease,16323,116,1.01 [0.86-1.19],0.8982100059866982
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23523,127,1.01 [0.87-1.17],0.9211083977249964
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22992,1210,1.02 [0.97-1.07],0.4501430367428474
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Neurological diseases,22321,3205,1.00 [0.97-1.03],0.7698123155682446
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23377,125,0.93 [0.79-1.08],0.3231494316271254
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22152,370,1.02 [0.94-1.12],0.6043531979706949
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23661,197,1.00 [0.89-1.13],0.9497904869649824
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19181,579,0.94 [0.88-1.01],0.0923424568851954
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23237,59,1.02 [0.82-1.28],0.8423061769494921
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23289,111,0.86 [0.73-1.00],0.0536822302046885
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23507,138,1.02 [0.88-1.18],0.7962220171153107
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21860,78,0.95 [0.78-1.15],0.597747711079389
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other headache syndromes,22274,68,1.08 [0.87-1.33],0.4750782821312617
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other neurological diseases,23612,434,1.00 [0.92-1.09],0.9244908501991916
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Other sleep disorders,22551,345,0.98 [0.90-1.08],0.7123521671325086
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Parkinson's disease,23688,140,1.00 [0.86-1.15],0.9508939436839348
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23250,72,1.12 [0.91-1.38],0.2839307413233028
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,23710,72,0.94 [0.77-1.15],0.5396997982566206
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Sleep apnoea,23558,278,0.97 [0.88-1.08],0.5938354871208913
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23498,34,1.13 [0.84-1.53],0.4156803120842183
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23702,141,0.94 [0.81-1.09],0.4064737931762149
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21840,58,1.00 [0.80-1.25],0.9954625314849408
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23711,324,0.95 [0.86-1.04],0.2641751379155588
APPL2,DCC-interacting protein 13-beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23253,91,0.95 [0.79-1.14],0.5780035610420957
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23204,91,0.96 [0.81-1.15],0.6906563991172219
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23313,419,0.95 [0.88-1.04],0.2781660612925954
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23591,140,1.00 [0.86-1.15],0.9725135053442996
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22745,53,1.04 [0.82-1.32],0.7695550923317186
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22736,44,1.18 [0.91-1.54],0.2162084672835762
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23602,58,1.12 [0.89-1.41],0.3293064814427913
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23458,144,0.92 [0.80-1.06],0.2742468217338829
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1471,29,1.00 [0.73-1.38],0.9809792471545126
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1753,56,0.90 [0.71-1.14],0.3846746097673832
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23197,84,0.89 [0.74-1.07],0.2126754640885174
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23560,904,1.04 [0.98-1.10],0.1755423786458194
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23341,649,0.98 [0.92-1.05],0.6336511732888301
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22954,262,1.00 [0.90-1.12],0.9462052539644148
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23637,743,0.96 [0.90-1.02],0.2234352518686946
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23701,62,0.99 [0.79-1.23],0.9147762905272396
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23568,674,0.96 [0.90-1.02],0.2105749812758664
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23673,359,0.97 [0.88-1.06],0.4769270103637905
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23627,183,0.91 [0.80-1.03],0.1324670899951807
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22730,38,1.13 [0.84-1.51],0.4177825794308195
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22732,40,1.31 [0.99-1.74],0.0622559287678632
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22753,61,1.04 [0.83-1.30],0.72403581563133
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23633,620,0.98 [0.92-1.05],0.5783561028950547
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23163,150,0.95 [0.82-1.09],0.4433993742525838
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22950,56,0.94 [0.74-1.18],0.572184019355555
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23405,91,1.01 [0.84-1.21],0.9217373556531796
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23591,277,0.95 [0.86-1.06],0.35463242768345
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23076,182,0.94 [0.83-1.07],0.3651106087268692
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23564,120,0.92 [0.79-1.08],0.3216357564945582
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23419,406,0.98 [0.90-1.06],0.6016424005523421
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23248,135,0.96 [0.83-1.11],0.6054897217499831
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22162,2207,1.01 [0.98-1.05],0.4583382776319744
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23556,242,0.96 [0.86-1.07],0.4467243323564094
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23691,139,1.00 [0.86-1.15],0.9484926592888951
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23030,338,1.01 [0.92-1.11],0.8390843648219375
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23373,59,0.97 [0.78-1.22],0.7990177093791668
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23687,48,1.03 [0.80-1.32],0.8442515600918395
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22775,83,0.88 [0.73-1.07],0.1948575782207835
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22822,130,0.91 [0.78-1.06],0.2085916557608235
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22749,93,1.10 [0.92-1.32],0.2944421099205888
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22953,59,0.96 [0.77-1.20],0.7117011514026345
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22713,57,0.87 [0.69-1.08],0.2046001392666631
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23117,104,0.96 [0.81-1.14],0.6529361304343877
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23167,154,0.94 [0.82-1.08],0.3529533683603499
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22804,112,1.06 [0.90-1.25],0.4771586380640793
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22738,82,1.21 [1.00-1.47],0.0549164559856703
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22715,59,1.08 [0.86-1.36],0.484389806420252
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21757,1802,0.98 [0.94-1.02],0.378775585152591
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22770,78,1.12 [0.92-1.37],0.2491562762928331
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23488,375,0.97 [0.89-1.06],0.5478595060525413
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23153,40,0.91 [0.69-1.18],0.4643968786397776
APPL2,DCC-interacting protein 13-beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23256,143,1.10 [0.95-1.27],0.2058169943751929
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23489,100,0.88 [0.74-1.04],0.1365779219662918
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23670,92,0.95 [0.80-1.14],0.5823250125813908
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23603,124,0.95 [0.81-1.11],0.4970008723988557
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23453,64,0.99 [0.80-1.22],0.912713087453298
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23453,64,1.04 [0.84-1.30],0.6958860009077206
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23620,700,1.00 [0.93-1.06],0.9123267926779556
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23399,479,1.02 [0.94-1.11],0.5867723799865587
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23023,103,0.93 [0.79-1.10],0.4272044791349071
APPL2,DCC-interacting protein 13-beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22996,76,1.14 [0.93-1.40],0.1943137454491851
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,23470,72,0.88 [0.72-1.08],0.2164482284141252
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23600,202,0.95 [0.84-1.07],0.36364245466723
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23451,53,1.03 [0.81-1.30],0.8347775435064939
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza,22228,114,0.96 [0.82-1.13],0.6368217458156793
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22227,113,0.97 [0.83-1.14],0.72753748211223
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16840,114,1.12 [0.95-1.32],0.1707444372115747
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,23593,246,1.13 [1.01-1.27],0.0266011120534173
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18383,1817,1.04 [1.00-1.09],0.037750725811848
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18519,1793,1.04 [1.00-1.09],0.0450284067776729
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23354,116,1.02 [0.87-1.20],0.7675553684864221
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22177,63,1.07 [0.86-1.33],0.540635591181196
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Bronchiectasis,20464,345,1.12 [1.02-1.23],0.0157451664668945
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20180,61,1.12 [0.89-1.40],0.3268335857462657
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22709,2590,1.04 [1.01-1.08],0.0235493494953588
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22606,57,0.91 [0.73-1.14],0.428734559984756
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,22676,127,1.10 [0.95-1.29],0.212583123843767
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23560,901,1.01 [0.95-1.07],0.7268065955273881
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,22612,63,1.09 [0.88-1.36],0.4329344460243094
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21891,4455,1.04 [1.01-1.07],0.0022831923822999
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22838,289,1.04 [0.94-1.15],0.4561006802887534
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Early onset COPD,22941,282,1.05 [0.94-1.16],0.4017913974620565
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Emphysema,20350,231,1.15 [1.02-1.29],0.017461863451934
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22259,204,0.95 [0.84-1.07],0.4139442694644955
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23534,1420,1.00 [0.95-1.05],0.9501372057806122
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,22294,239,0.97 [0.87-1.08],0.5597958543527501
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Later onset COPD,22904,619,1.00 [0.93-1.07],0.9920552628134236
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23706,185,0.97 [0.85-1.10],0.6355743814078442
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Nasal polyp,22610,61,1.06 [0.85-1.32],0.5971425820025436
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23508,813,1.02 [0.96-1.08],0.5627124381587365
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,23546,1514,1.02 [0.97-1.06],0.456339761285125
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23229,680,1.10 [1.03-1.17],0.0055632180872093
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other pleural conditions,22067,35,0.80 [0.60-1.06],0.115822106975909
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23634,301,0.96 [0.87-1.05],0.365580958983505
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23634,1029,1.04 [0.98-1.10],0.1620599377758663
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural effusion,22752,720,1.02 [0.95-1.08],0.633280645229958
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pleural plaque,22073,41,1.08 [0.82-1.42],0.5721395965303533
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23320,1206,0.99 [0.94-1.04],0.7092942259824966
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23678,157,0.94 [0.82-1.08],0.3964796302130384
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pneumothorax,22120,88,0.96 [0.80-1.15],0.669060712542545
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pollen allergy,23690,208,1.11 [0.98-1.25],0.0920494829233623
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,23385,52,0.84 [0.67-1.06],0.1428019286429094
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16767,41,1.30 [0.98-1.72],0.0695435178139851
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23489,794,1.01 [0.95-1.07],0.7363098594968756
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22795,246,1.14 [1.02-1.27],0.0232961607692522
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Viral pneumonia,22299,185,1.01 [0.89-1.14],0.9221656128617798
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23362,145,1.00 [0.87-1.16],0.9664125671757096
APPL2,DCC-interacting protein 13-beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11409,91,1.03 [0.85-1.23],0.787998966787019
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16949,34,0.99 [0.74-1.34],0.967720811032102
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute appendicitis,23544,122,0.79 [0.68-0.92],0.0025179040991626
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute gastritis,17804,71,1.01 [0.82-1.24],0.9422752233764
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,21743,141,1.12 [0.97-1.30],0.1217283134294631
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Acute peritonitis,23213,73,1.14 [0.93-1.40],0.2039016781250364
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22968,33,0.91 [0.68-1.23],0.5481481426139705
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,18033,300,1.10 [0.99-1.22],0.0663540472893176
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21672,70,1.14 [0.92-1.41],0.2228211311032832
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23344,70,1.14 [0.92-1.41],0.2199336144575913
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholecystitis,21757,155,0.97 [0.85-1.11],0.6697458750440828
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Cholelithiasis,22626,1024,0.98 [0.93-1.04],0.5108948433504813
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic gastritis,18023,290,1.10 [0.99-1.22],0.0671533154963507
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21639,37,0.89 [0.68-1.18],0.4260121168392338
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23641,67,0.85 [0.69-1.05],0.1272281276516697
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Coeliac disease,22385,127,1.03 [0.88-1.20],0.7181999102008115
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Collagenous colitis,22060,95,0.99 [0.83-1.19],0.9406357656381996
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23588,138,1.01 [0.87-1.17],0.9007569227377196
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Constipation,23422,1461,1.00 [0.96-1.05],0.8803287850520679
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn disease,22041,76,1.05 [0.86-1.29],0.6062243619265746
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23398,53,1.00 [0.79-1.27],0.993714136005376
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22042,77,1.05 [0.86-1.28],0.6117376710493974
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Dental caries,22993,196,0.99 [0.88-1.12],0.9293843163716622
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22281,2104,1.01 [0.97-1.05],0.5748619738956938
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of appendix,23580,158,0.88 [0.77-1.01],0.0605665834129265
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of liver,23624,689,1.03 [0.96-1.10],0.4548705050100617
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21719,3986,1.00 [0.97-1.03],0.9184300730301695
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23307,510,1.01 [0.93-1.09],0.8685344911954098
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23609,469,1.06 [0.98-1.14],0.1784732323826112
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22902,105,0.98 [0.83-1.15],0.7771562401094324
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22771,57,1.03 [0.82-1.30],0.7825629978889578
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23459,1201,1.01 [0.96-1.06],0.8298772957686695
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diseases of tongue,22772,90,1.01 [0.84-1.21],0.909805195932088
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22969,1367,1.00 [0.96-1.05],0.9161821109037248
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19682,2767,1.01 [0.98-1.05],0.4419834033810368
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,17850,117,1.05 [0.89-1.23],0.5803484910800407
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23662,97,1.02 [0.86-1.22],0.826545828339748
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23628,56,1.20 [0.95-1.51],0.1301490751956006
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23020,85,0.89 [0.74-1.08],0.2353238501231365
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17015,100,1.09 [0.91-1.29],0.3486755237027414
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,18318,585,1.03 [0.96-1.10],0.439882692332507
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastric ulcer,18032,299,0.91 [0.83-1.01],0.0729709421716011
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20140,2407,1.01 [0.97-1.04],0.7416778194229117
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18146,413,0.94 [0.86-1.02],0.1440364208999121
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18535,7247,1.01 [0.99-1.03],0.4516215793383569
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,GI-bleeding,23216,958,0.99 [0.94-1.05],0.7736886353279482
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22856,59,0.96 [0.76-1.20],0.689797886218616
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17764,1095,1.06 [1.01-1.12],0.0256293366695627
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22968,33,0.79 [0.59-1.05],0.1035492513780835
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Hernia,22666,2489,1.00 [0.97-1.04],0.9338960829361092
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impacted teeth,23636,51,1.28 [1.00-1.63],0.0498717820487882
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Impaction of intestines,16973,58,1.19 [0.94-1.50],0.1417004384631817
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Inguinal hernia,20325,148,0.91 [0.79-1.05],0.1973404598251644
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16999,84,0.91 [0.76-1.10],0.3462980699245834
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22412,154,1.06 [0.92-1.22],0.4237023090846235
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17614,699,1.04 [0.97-1.11],0.2365789526615521
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23699,302,1.17 [1.06-1.30],0.0020603237842947
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22674,709,1.09 [1.02-1.16],0.0122301799599247
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22918,953,1.09 [1.03-1.15],0.0044554705291015
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17865,132,1.06 [0.91-1.24],0.4378684561407292
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oesophagitis,18229,496,1.02 [0.95-1.10],0.5832264687139801
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23670,135,1.05 [0.90-1.22],0.5317844864948749
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20231,54,1.09 [0.86-1.38],0.4809906455191802
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18005,1090,1.03 [0.97-1.08],0.3295598255706597
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21853,251,0.98 [0.88-1.10],0.7551602157859724
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21765,163,0.92 [0.80-1.05],0.1925212204296708
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,18296,1381,1.01 [0.96-1.06],0.7302429468455349
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,21828,4913,1.01 [0.98-1.03],0.5820696012126034
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22772,198,1.03 [0.92-1.17],0.5847887614296322
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of liver,23506,571,1.04 [0.97-1.12],0.2448133291625323
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18251,518,1.02 [0.95-1.10],0.6081611341064411
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21735,133,0.91 [0.79-1.06],0.2290379393166484
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23553,413,1.04 [0.95-1.13],0.3874306479503389
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18664,931,0.99 [0.94-1.05],0.7419510778311058
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23233,975,0.99 [0.94-1.05],0.8342147558705472
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22951,154,0.99 [0.86-1.14],0.8691495910601358
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18427,1512,1.01 [0.97-1.05],0.6881250047967875
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19538,1805,0.96 [0.92-1.00],0.0631728723813555
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23026,91,0.93 [0.78-1.12],0.4428793708073388
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22804,839,1.07 [1.01-1.13],0.0295064341731561
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17202,287,1.00 [0.90-1.10],0.9264211298161316
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23619,65,1.18 [0.95-1.46],0.1389021279403724
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17343,428,0.96 [0.89-1.04],0.3577827940833531
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22377,119,1.00 [0.85-1.17],0.965237327857586
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23703,62,0.88 [0.71-1.09],0.2405100916224345
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22797,110,0.93 [0.79-1.10],0.3932800169871593
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Toxic colitis,22020,55,1.02 [0.81-1.29],0.8778654458439625
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17943,210,1.09 [0.97-1.23],0.1520129837784221
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,22114,149,1.21 [1.05-1.40],0.0093673953611903
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22091,126,1.21 [1.04-1.42],0.0147111687396594
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Umbilical hernia,20331,154,0.91 [0.80-1.05],0.1925035334965435
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17079,164,0.97 [0.85-1.11],0.6373025032911571
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Ventral hernia,20396,219,0.98 [0.88-1.11],0.783030492501687
APPL2,DCC-interacting protein 13-beta,Chapter XI Diseases of the digestive system,Volvulus,16990,75,0.92 [0.76-1.12],0.3985521426614865
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23637,214,1.12 [0.99-1.26],0.0740023291988306
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23435,75,0.85 [0.70-1.03],0.0980928387017543
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21924,193,1.05 [0.93-1.19],0.4239240395795153
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23239,546,0.99 [0.92-1.06],0.7516801389413642
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22821,128,1.01 [0.87-1.17],0.9112669736646928
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22008,277,0.92 [0.83-1.02],0.0944482748991845
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23434,239,1.05 [0.94-1.17],0.3888822364764603
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23610,415,0.98 [0.90-1.06],0.5840867485020049
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23240,45,0.89 [0.69-1.14],0.3432126101773848
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22328,2741,1.00 [0.96-1.03],0.8346410093097894
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23327,402,0.92 [0.85-1.01],0.0687326674016015
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23200,275,0.97 [0.87-1.07],0.5490248470606323
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23429,736,0.98 [0.92-1.04],0.5115096379486375
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23693,66,0.99 [0.80-1.22],0.903676962927839
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21816,85,0.86 [0.72-1.03],0.104030628301461
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22964,39,0.98 [0.74-1.29],0.8701738673041448
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23420,225,1.06 [0.94-1.19],0.3548175903634128
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22098,367,1.09 [0.99-1.19],0.0708372040463872
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21779,48,1.02 [0.80-1.31],0.8490714792881077
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23620,67,0.81 [0.66-0.99],0.0438925661093254
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22829,136,1.08 [0.93-1.26],0.3047529563895851
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23509,149,0.79 [0.69-0.91],0.0008363537912799
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23236,41,0.92 [0.70-1.20],0.5203963638867013
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21787,56,1.05 [0.83-1.32],0.6710899748444334
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23121,1390,1.01 [0.97-1.06],0.5524585028008311
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22128,397,1.09 [0.99-1.18],0.0666922538060472
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21783,52,1.04 [0.82-1.31],0.7769109176676701
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23638,278,0.88 [0.80-0.98],0.0149911965651881
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23270,75,0.82 [0.67-0.99],0.0395525955395476
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23575,215,0.85 [0.76-0.96],0.0070719804553416
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23664,241,1.09 [0.98-1.22],0.1228356091482329
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21870,139,1.08 [0.94-1.26],0.2792050186436443
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21959,228,1.07 [0.95-1.20],0.2626621736047737
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23653,230,1.09 [0.97-1.23],0.1270624937399905
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21909,178,1.00 [0.88-1.14],0.9413365871806072
APPL2,DCC-interacting protein 13-beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23679,126,0.88 [0.76-1.03],0.1077873496209018
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20235,114,1.12 [0.95-1.31],0.1828550497422812
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21522,5518,0.99 [0.97-1.02],0.6151395911259916
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20315,4311,1.00 [0.98-1.03],0.7448343537565245
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20188,67,1.02 [0.83-1.26],0.842882018416891
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20332,137,1.03 [0.89-1.19],0.733001451555521
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20376,181,1.02 [0.90-1.16],0.7237226107786839
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23464,103,0.83 [0.71-0.98],0.030522487420585
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20298,103,0.94 [0.80-1.11],0.4778532099149807
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17202,1198,0.99 [0.95-1.05],0.8206580817198992
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23579,200,1.00 [0.89-1.13],0.9474822390557116
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20696,501,1.03 [0.95-1.11],0.4982633555988051
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19909,7025,1.00 [0.98-1.02],0.8734682355564534
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21226,115,0.97 [0.83-1.14],0.7052396664002971
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20239,118,1.06 [0.90-1.24],0.5069358027147506
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20722,601,1.03 [0.96-1.10],0.4372800118948959
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22816,2621,1.01 [0.98-1.05],0.3894386724210948
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20276,155,1.02 [0.89-1.18],0.7274918216843882
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20458,337,1.11 [1.01-1.22],0.0354502976943803
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20273,152,1.19 [1.03-1.37],0.0189886059807757
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22849,90,0.91 [0.76-1.09],0.3108500347433321
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17628,1624,1.01 [0.97-1.05],0.659952828209305
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16183,179,1.04 [0.92-1.19],0.5335156291211369
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23698,176,1.01 [0.89-1.16],0.8488188894071041
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16096,92,1.02 [0.85-1.22],0.821719436468761
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16508,504,0.90 [0.84-0.97],0.0087174393743124
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20412,291,0.95 [0.86-1.05],0.3625449495995508
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16552,548,0.99 [0.92-1.07],0.8427065504033988
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20253,58,1.19 [0.94-1.50],0.1387347843600717
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20814,619,1.05 [0.98-1.13],0.1412538611093969
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20486,291,1.01 [0.91-1.11],0.883381332241431
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16514,510,1.00 [0.93-1.08],0.9624066839776202
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20193,72,1.15 [0.94-1.41],0.1759833593665512
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20183,62,1.04 [0.83-1.29],0.7411788590311781
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21156,45,1.09 [0.84-1.42],0.5133321769140982
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23298,2187,0.97 [0.94-1.01],0.1401740863967072
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22680,1569,0.97 [0.93-1.01],0.1884460957915878
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23528,518,1.04 [0.96-1.12],0.36244944574761
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18632,2628,1.00 [0.97-1.03],0.9338856837833454
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16063,59,0.99 [0.79-1.24],0.9134087793807651
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20210,89,1.20 [1.00-1.45],0.0495692503154959
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16046,42,0.93 [0.71-1.21],0.5903378888459202
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16181,177,1.03 [0.90-1.17],0.6780765216142454
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21372,261,0.91 [0.82-1.02],0.0982590370769508
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21607,496,0.94 [0.87-1.01],0.1076598291668067
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23689,97,1.07 [0.90-1.28],0.4289735925215155
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21962,1767,1.03 [0.99-1.07],0.1920568465983025
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20235,114,0.94 [0.80-1.10],0.4121670762995023
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16209,205,0.90 [0.80-1.02],0.0996873663950987
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20895,700,1.00 [0.94-1.07],0.9883276964578346
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18216,2212,0.99 [0.95-1.02],0.4280096343818805
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22871,112,0.94 [0.80-1.10],0.4287770960339336
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23693,73,0.89 [0.73-1.09],0.2709626553304912
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20189,68,1.14 [0.93-1.42],0.2118871267122503
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21400,1279,1.04 [0.99-1.09],0.1472316970404499
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20192,71,1.09 [0.89-1.34],0.402776081134959
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17730,1726,1.04 [1.00-1.08],0.0702998325170031
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21239,128,0.97 [0.83-1.13],0.6767817093164861
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20170,49,0.92 [0.72-1.17],0.4945767238453276
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20368,173,0.98 [0.86-1.11],0.7246332635786494
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20620,499,1.00 [0.92-1.08],0.947426214228765
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23205,446,1.10 [1.01-1.19],0.0261305978965493
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20753,558,1.03 [0.96-1.11],0.4594374504360841
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23540,501,1.04 [0.97-1.13],0.289891503873016
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23686,57,1.20 [0.95-1.52],0.1193139554207298
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20315,194,0.98 [0.87-1.11],0.7250614315139341
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18179,795,1.02 [0.96-1.08],0.6142313985908618
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20697,576,1.01 [0.94-1.08],0.8215158852584517
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20227,106,1.07 [0.91-1.27],0.4209843778732497
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16078,74,0.95 [0.78-1.16],0.6168787228619064
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18302,2298,1.03 [0.99-1.06],0.145558689087771
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16734,730,1.01 [0.95-1.07],0.8172273344639482
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23011,252,1.14 [1.02-1.28],0.0187008014062795
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23662,70,0.99 [0.80-1.21],0.9025053386925854
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21729,48,1.15 [0.89-1.47],0.2832863626229005
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16078,74,0.88 [0.72-1.07],0.198303427196935
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20292,97,1.07 [0.90-1.28],0.4272874683550961
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16525,521,1.04 [0.96-1.12],0.3281223789311194
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20404,283,0.92 [0.83-1.02],0.1028626221606176
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20442,247,1.08 [0.97-1.21],0.1616562720646417
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20431,236,1.00 [0.89-1.12],0.986448018268088
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18287,78,1.15 [0.95-1.41],0.155941981449219
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23692,63,1.09 [0.87-1.35],0.4622252320893829
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20673,552,1.00 [0.93-1.07],0.9585035044149626
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22909,150,1.04 [0.90-1.20],0.5895510861200031
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22569,2448,1.03 [0.99-1.06],0.1454783598162336
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20257,136,0.87 [0.76-1.01],0.0637155327223048
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20676,481,1.05 [0.97-1.14],0.2377879675523288
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22184,224,0.96 [0.86-1.08],0.4967506226988528
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20408,213,1.04 [0.92-1.17],0.5001455895303926
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21704,1509,0.99 [0.94-1.03],0.5715258228104938
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21220,1025,0.98 [0.93-1.03],0.3967828703093795
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20177,56,1.11 [0.88-1.40],0.3924116868859474
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22972,213,0.95 [0.85-1.07],0.3877876174073579
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20296,175,0.99 [0.87-1.12],0.8476640854410603
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20235,114,0.92 [0.78-1.08],0.3032204469188294
APPL2,DCC-interacting protein 13-beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16049,45,1.16 [0.89-1.51],0.2622954645538029
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22868,1031,1.00 [0.94-1.05],0.8827264554040318
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17745,86,1.09 [0.90-1.31],0.3691439510805746
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23115,100,0.95 [0.80-1.13],0.5848387254893235
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23573,198,1.06 [0.94-1.20],0.3186846856241337
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23397,22,0.67 [0.47-0.95],0.0238135939760127
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22992,1155,0.97 [0.92-1.02],0.1706319988743309
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23571,58,0.82 [0.65-1.02],0.0700464738471599
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23539,205,1.00 [0.89-1.13],0.9667499275067472
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Cystitis,20951,220,0.93 [0.83-1.05],0.2303081120204975
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Dialysis,21881,44,1.27 [0.97-1.66],0.0770359179949655
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23297,282,0.98 [0.89-1.09],0.7552434465841141
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,17808,149,1.02 [0.89-1.17],0.7836462489594043
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17994,335,0.90 [0.82-0.99],0.02938160343049
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18515,856,1.03 [0.97-1.09],0.3402292405946677
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18416,4267,0.99 [0.96-1.02],0.4802618698123114
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23565,52,1.02 [0.81-1.29],0.8655181000403007
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21720,180,0.91 [0.81-1.04],0.1628548737211353
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23229,344,0.96 [0.87-1.05],0.3660077805093088
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,23311,107,0.76 [0.65-0.89],0.0008797079424518
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17921,262,1.00 [0.90-1.11],0.976849248725521
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20796,65,1.02 [0.82-1.26],0.8885573172901553
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19753,2094,0.99 [0.95-1.03],0.5469495346107943
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17780,121,1.03 [0.88-1.20],0.7284393931397427
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23702,57,1.14 [0.90-1.44],0.2687520867296261
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23702,71,0.93 [0.76-1.14],0.5003902703697052
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22622,1891,0.99 [0.95-1.03],0.523424326970255
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21141,410,0.98 [0.90-1.07],0.7132789545992968
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23114,99,1.03 [0.86-1.22],0.7664492676520696
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23660,326,1.04 [0.94-1.14],0.4397048854519456
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23657,77,1.12 [0.91-1.36],0.2795064633347834
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22352,1621,0.99 [0.95-1.04],0.7092201939321878
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23064,179,1.00 [0.88-1.14],0.9972463942224882
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17792,133,1.14 [0.98-1.33],0.0843559333288014
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17994,335,1.02 [0.93-1.12],0.6581187689746912
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17762,103,1.05 [0.88-1.24],0.5952365477208912
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17841,182,1.01 [0.89-1.15],0.8654504664201724
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21766,226,0.96 [0.86-1.07],0.4715945826080105
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23440,106,1.11 [0.94-1.31],0.2309476748208639
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17911,252,0.99 [0.89-1.10],0.8425426172120268
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17749,90,0.96 [0.80-1.15],0.6734940756332527
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18206,547,0.98 [0.91-1.05],0.5980533504923163
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17798,139,1.01 [0.88-1.17],0.8568403753934535
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18164,505,1.00 [0.93-1.08],0.9443360253940866
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23546,33,1.11 [0.82-1.50],0.4925186296070054
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23555,2015,0.98 [0.95-1.02],0.3917562010542209
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21684,144,1.02 [0.88-1.17],0.8143579245817516
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21922,85,1.03 [0.85-1.24],0.7782575360651146
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23406,31,0.90 [0.67-1.23],0.5154929079412269
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20855,124,1.04 [0.89-1.22],0.5896808838980199
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23604,229,1.03 [0.92-1.16],0.5734013873063861
APPL2,DCC-interacting protein 13-beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17778,119,1.07 [0.92-1.26],0.3844725746026297
